(globalThis.TURBOPACK||(globalThis.TURBOPACK=[])).push(["object"==typeof document?document.currentScript:void 0,75792,e=>{"use strict";var s=e.i(47167),a=e.i(43476);let t=s.default.env.NEXT_PUBLIC_BASE_PATH??"";function i(){return(0,a.jsx)("section",{id:"about",children:(0,a.jsxs)("div",{className:"flex flex-col md:flex-row gap-8 items-start",children:[(0,a.jsx)("div",{className:"shrink-0",children:(0,a.jsx)("div",{className:"size-32 md:size-40 rounded-full overflow-hidden ring-1 ring-neutral-200 bg-neutral-100",children:(0,a.jsx)("img",{src:`${t}/debora-portrait.jpg`,alt:"Débora Joppi",className:"w-full h-full object-cover"})})}),(0,a.jsxs)("div",{className:"flex-1",children:[(0,a.jsx)("h1",{className:"text-2xl font-semibold tracking-tight",children:"About"}),(0,a.jsxs)("p",{className:"mt-3 text-neutral-700 leading-relaxed",children:["Postdoctoral researcher at Charité (Berlin). I study how mutations in"," ",(0,a.jsx)("em",{children:"PRC1.1"})," (USP7, PCGF1, BCOR, KDM2B) reshape chromatin and drive DLBCL. I integrate functional assays with spatial genomics and structure-guided models (AlphaFold, PyMOL) to generate mechanistic & biomarker hypotheses."]}),(0,a.jsx)("ul",{className:"mt-4 grid sm:grid-cols-2 gap-2 text-sm text-neutral-700",children:["Cancer epigenetics (PRC1.1: USP7, PCGF1, BCOR, KDM2B)","Functional & spatial genomics (CUT&Tag, ChIP-seq, RNA-seq)","Structure-guided hypotheses (AlphaFold, PyMOL)","DLBCL mechanistic models & biomarkers"].map(e=>(0,a.jsxs)("li",{className:"flex items-start gap-2",children:[(0,a.jsx)("span",{className:"mt-[6px] size-1.5 rounded-full bg-neutral-400"}),(0,a.jsx)("span",{children:e})]},e))})]})]})})}e.s(["default",()=>i])}]);